Drug interactions in primary care: Impact of a new algorithm on risk determination

被引:59
作者
Bergk, V
Gasse, C
Rothenbacher, D
Loew, M
Brenner, H
Haefeli, WE
机构
[1] Heidelberg Univ, Dept Internal Med 6, Clin Pharmacol & Pharmacoepidemiol, D-69120 Heidelberg, Germany
[2] Heidelberg Univ, Dept Epidemiol, German Ctr Res Ageing, Heidelberg, Germany
关键词
D O I
10.1016/j.clpt.2004.02.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: If managed adequately, many drug interactions do not result in clinical manifestations. Earlier studies may have overestimated the risk arising from drug interactions because they usually reported interaction frequencies and the severity of potential outcomes irrespective of their manageability. Objective: Our objective was to estimate the risk associated with drug interactions in a large population when not only the severity of possible clinical events but also measures of their prevention (manageability, modulating factors) are considered. Methods. We evaluated all drug pairs concurrently prescribed to 9481 adults aged 50 to 75 years who participated in a health-screening examination. Drug interactions were evaluated by use of an algorithm with 4 decision layers (severity, manageability, risk/benefit assessment, and patient-related risk factors), and this risk evaluation was compared with the conventional evaluation solely on the basis of severity. Results. More than 52% of the patients received combination therapy. Interaction information was available in a standard source (DRUGDEX; Thomson MICROMEDEX, Greenwood Village, Colo) for only 1029 of all 13,672 individual prescribed drug pairs. Of the drug pairs, 881 (6.4%) were identified as interacting. Of these 881 interactions, 132 (15.0%) were of major severity but 101 of 132 (76.5%) were considered manageable. Only 31 (23.5%) of 132 major interactions (ie, 31/881 [3.5% of all interacting pairs]) offered no management options and should thus be avoided. Conclusion: For many commonly prescribed drug pairs, explicit drug interaction information is currently not available in DRUGDEX. For major interactions with published evidence, the overwhelming majority were manageable, and therefore risk estimates only based on the severity of potential outcomes will grossly overestimate the risk associated with such combinations.
引用
收藏
页码:85 / 96
页数:12
相关论文
共 44 条
  • [1] INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION
    BATES, DW
    CULLEN, DJ
    LAIRD, N
    PETERSEN, LA
    SMALL, SD
    SERVI, D
    LAFFEL, G
    SWEITZER, BJ
    SHEA, BF
    HALLISEY, R
    VANDERVLIET, M
    NEMESKAL, R
    LEAPE, LL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01): : 29 - 34
  • [2] POTENTIAL DRUG-DRUG INTERACTIONS IN 5,125 MOSTLY ELDERLY OUT-PATIENTS IN GOTHENBURG, SWEDEN
    BERGENDAL, L
    FRIBERG, A
    SCHAFFRATH, A
    [J]. PHARMACY WORLD & SCIENCE, 1995, 17 (05): : 152 - 157
  • [3] Polypharmacy: Correlations with sex, age and drug regimen - A prescription database study
    Bjerrum, L
    Sogaard, J
    Hallas, J
    Kragstrup, J
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (03) : 197 - 202
  • [4] Exposure to potential drug interactions in primary health care
    Bjerrum, L
    Andersen, M
    Petersen, G
    Kragstrup, J
    [J]. SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2003, 21 (03) : 153 - 158
  • [5] Drug-drug interactions in the elderly
    Björkman, IK
    Fastbom, J
    Schmidt, IK
    Bernsten, CB
    [J]. ANNALS OF PHARMACOTHERAPY, 2002, 36 (11) : 1675 - 1681
  • [6] UNPREDICTABLE RESPONSE TO NIFEDIPINE IN SEVERE CARDIAC-FAILURE
    BROOKS, N
    CATTELL, M
    PIDGEON, J
    BALCON, R
    [J]. BRITISH MEDICAL JOURNAL, 1980, 281 (6251) : 1324 - 1324
  • [7] POTENTIAL-DRUG INTERACTIONS IN AN AMBULATORY GERIATRIC POPULATION
    COSTA, AJ
    [J]. FAMILY PRACTICE, 1991, 8 (03) : 234 - 236
  • [8] DRUG-INTERACTIONS IN A CLINIC USING COSTAR
    DAMBRO, MR
    KALLGREN, MA
    [J]. COMPUTERS IN BIOLOGY AND MEDICINE, 1988, 18 (01) : 31 - 38
  • [9] EAST C, 1988, NEW ENGL J MED, V318, P47
  • [10] Adverse drug reactions: definitions, diagnosis, and management
    Edwards, IR
    Aronson, JK
    [J]. LANCET, 2000, 356 (9237) : 1255 - 1259